510(k) K770459
K770459 is an FDA 510(k) premarket notification submitted by Icn Pharmaceuticals, Inc. for the device "URIC ACID PROCEDURE, TEKPOINT DIRECT". The FDA issued a decision of Substantially Equivalent on Apr 29, 1977. The device falls under product code CDH (Acid, Uric, Phosphotungstate Reduction), a Class I device regulated under 21 CFR 862.1775. Icn Pharmaceuticals, Inc. has 29 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Apr 29, 1977
- Date Received
- Mar 8, 1977
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Acid, Uric, Phosphotungstate Reduction
- Device Class
- Class I
- Regulation Number
- 862.1775
- Review Panel
- CH
- Submission Type
- 510(k) Exempt
Need the full FDA record for Icn Pharmaceuticals, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.